Amar Puttanna is a diabetes and endocrine consultant in the West Midlands. He is particularly interested in education, having won teaching awards from the University of Birmingham and the Royal College of Physicians of Edinburgh. He currently sits on the MRCP Part 1 examining board. In 2018, he received an Excellence in Patient Care Award from the Royal College of Physicians for his contribution to the profession.

He is involved in writing guidelines, including those on older adults with diabetes with the Joint British Diabetes Societies (JBDS) and guidelines/patient leaflets on diabetes and dementia. He has also worked on local guidelines for type 2 diabetes management, including areas such as cardiovascular disease and frailty.

He sits on the editorial board for the British Journal of Cardiology, is involved in a nationwide education programme for care homes. He has been an invited speaker at national and international conferences.

Dr Puttanna’s interests are in cardiovascular disease, diabetes management in older adults including cognitive impairment and translating research into clinical practice, sustainability in diabetes care and he is active on social media (@AmarPut). His work in cognitive impairment (DIADEM project) won a Quality in Care award in 2018.

NOTE: Since this biography was written, Dr Puttanna has become National Advisor for Clinical Engagement for the pharmaceutical company Sanofi. As of January 2022, he will no longer be setting assessments for the EASD e-Learning platform.

Duality of Interest: Dr Puttanna has been an employee of Sanofi since 2022 and has received speaker’s fees/honoraria from Novo Nordisk and Astra Zeneca.
Date: Summer 2023